Treatment of granuloma annulare with topical 5% imiquimod cream [3]

Pediatric Dermatology

Volumn 20, Issue 1, 2003, Pages 90-

  Kuwahara, Raymond T ^a   Naylor, Mark F ^a   Skinner, Robert B ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

IMIQUIMOD; AMINOQUINOLINE DERIVATIVE; EMOLLIENT AGENT;

CASE REPORT; CLINICAL FEATURE; DRUG ACTIVITY; DRUG APPROVAL; DRUG INDICATION; ETHNOLOGY; FEMALE; FOOD AND DRUG ADMINISTRATION; GRANULOMA ANNULARE; HUMAN; IMMUNE RESPONSE; LETTER; PRIORITY JOURNAL; SCHOOL CHILD; CHILD; FOLLOW UP; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, TOPICAL; AMINOQUINOLINES; CHILD; EMOLLIENTS; FEMALE; FOLLOW-UP STUDIES; GRANULOMA ANNULARE; HUMANS; TREATMENT OUTCOME;

EID: 0041821998     PISSN: 07368046     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1470.2003.30234.x     Document Type: Letter

References (4)

1. Sandwich JT, Davis LS. Granuloma annulare of the eyelid: a case report and review of the literature. Pediatr Dermatol 1999;16:373-376.
2. Marks R, Gebauer K, Shumack S, et al. Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial. J Am Acad Dermatol 2001;44:807-813.
3. Skinner RB Jr, Ray S, Talanin NY. Treatment of molluscum contagiosum with topical imiquimod cream. Pediatr Dermatol 2000;17:420.
4. Stockfleth E, Meyer T, Benninghoff B, Christophers E. Successful treatment of actinic keratosis with imiquimod cream 5%: a report of six cases. Br J Dermatol 2001;144:1050-1053.